GLP-1 Titration Planner
The difference between flat and dose-dependent prices can change what you pay over the full schedule. This tool models the timing and cost of the labeled dose steps.
| Weeks | Dose | What the label calls it |
|---|---|---|
| 1–4 | 0.25 mg | initiationThe label lists this as the starting dose. |
| 5–8 | 0.5 mg | escalation |
| 9–12 | 1 mg | escalation |
| 13–16 | 1.7 mg | escalation |
| 17+ | 2.4 mg | maintenanceThe dose STEP 1 studied, where the −14.9% mean change was measured. |
Reaching 2.4 mg takes 17 weeks on this schedule, so a buyer spends roughly 31% of a first year below it. The label also lists 7.2 mg as a maintenance option above this ladder; the weeks to reach it are not carried here, so it is not priced above. Source: Wegovy prescribing information, DailyMed.
What the ladder costs, two ways
The same escalation, priced by a seller that holds one figure across every dose and by one that raises it at each step. Put in any two numbers you are comparing.
Flat at every dose
$1,788
across a first year
Priced by dose
$2,351
across a first year
On these figures the dose-indexed seller costs $563 more across the year, despite opening $50 lower a month.
These are the approved products’ schedules
The cost examples use schedules from the prescribing information for Wegovy and Zepbound. A quoted price for a compounded product may cover different strengths or supply periods. If a quote gives a four-week supply, our 28-day billing guide explains what to ask about the time between charges. Confirm those terms before using the example to estimate your bill.
These examples illustrate how different pricing terms affect costs over time. Your clinician determines which dose and schedule are appropriate for you.